- 英文名称
- ginsenoside F4
- 分子式
- C42H70O12
- 分子量
- 767
- 中文别名
- (20E)-人参皂苷F4; (2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-二羟基-4,4,8,10,14-五甲基-17-((E)-6-甲基庚-2,5-二烯-2-基)十六氢-1H-环戊并[a]菲-6-基)氧基)-4,5-二羟基-6-(羟甲基)四氢-2H-吡喃-3-基)氧基)-6-甲基四氢-2H-吡喃-3,4,5-三醇; 人参皂苷 F4; (20E)-Ginsenoside F4; Ginsenoside F4 (20E); GINSENOSIDE F4 (GF4); β-D-Glucopyranoside, (3β,6α,12β,20E)-3,12-dihydroxydammara-20(22),24-dien-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-; (2S,3R,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-4,4,8,10,14-pentamethyl-17-((E)-6-methylhepta-2,5-dien-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-methyltetrahydro-2H-pyran-3,4,5-triol; (3β,6α,12β,20E)-3,12-Dihydroxydammara-20(22),24-dien-6-yl (3ξ)-2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-ribo-hexopyranoside
- 用途
- 作为色谱标准品；用于中草药成分分析；作为制药原料；用于含量测定、鉴定及药理实验；具有生物活性，可诱导人淋巴细胞瘤JK细胞凋亡，抑制IL-1β处理的软骨细胞中MMP-13的表达，防止软骨组织损坏，还可通过降解人参皂苷Re制备，作为免疫佐剂。
